Minova Life Science

Minova life sciences - Pharmaceutical company

Visvas-10 Tablets

COMPOSITION – Atorvastatin  IP 10 mg

Statins represent a vital therapy for patients with dyslipidemia and for attenuating cardiovascular (CV) risk in both primary and secondary prevention.

Patients who received statin treatment demonstrated a 20% to 30% reduction in death and major cardiovascular events compared with patients who received placebo.


Class of medications: HMG-CoA reductase inhibitors (statins)

Atorvastatin Calcium

  • Effectively decreases the coenzyme Q₁0 level in the blood of the patients at risk for cardiovascular diseases and stroke.
  • Reduces recurrent Ischemic events in patients with the acute coronary syndrome.
  • Efficiently achieves Plasma LDL cholesterol reduction up to 61% in patients with high LDL count.

Explore other products

Scroll to Top